Medical LLMs have reached a decisive inflection point in 2026: Meditron-70B, Med-PaLM 2, and BioMedGPT each demonstrate that purpose-built clinical models consistently outperform general-purpose frontier models on clinical benchmarks — and the performance gap is widest precisely where patient safety risks are highest. This detailed comparison covers architecture, benchmark performance, deployment model, and the clinical use cases where each model excels to help healthcare technology leaders make evidence-based model selection decisions.
The Medical LLM Landscape in 2026
Meditron-70B: The Open-Weight Clinical Standard
Meditron-70B, from EPFL and Stanford Medicine, is the most important open-weight medical LLM in 2026. Built on LLaMA 2 70B with continued pre-training on 48.1 billion tokens of curated medical text (PubMed papers, clinical guidelines, medical case discussions), it matches GPT-4's performance on medical benchmarks at a fraction of the API cost — and can be self-hosted for full data sovereignty.
| Benchmark | Meditron-70B | Med-PaLM 2 | GPT-4 (baseline) | GPT-4o |
|---|---|---|---|---|
| USMLE Step 1 | 72.3% | 85.4% | 75.0% | 78.2% |
| USMLE Step 2 CK | 74.9% | 86.5% | 72.2% | 77.1% |
| MedQA (4-option) | 70.2% | 79.7% | 75.1% | 78.4% |
| MedMCQA | 67.1% | 71.3% | 69.5% | 72.8% |
| PubMedQA | 76.5% | 81.8% | 74.4% | 75.2% |
| Self-hostable? | Yes — full open-weight | No — Google Cloud only | No — API only | No — API only |
Med-PaLM 2: The Frontier Clinical Model
Google DeepMind's Med-PaLM 2 leads all medical LLMs on clinical benchmarks in 2026 — its 85.4% on USMLE Steps 1–3 exceeds the average passing score of 60% and approaches the expert physician performance of 87%. It is available through Google Cloud Healthcare API and is the appropriate choice when maximum clinical accuracy is required and Google Cloud infrastructure is acceptable.
BioMedGPT: The Biomedical Research Model
BioMedGPT (BioMap/PharmaAI) is specialised for biomedical research tasks — drug-protein interaction prediction, molecular property prediction, biomedical NER, and scientific literature mining. Its multimodal architecture can process both text and molecular structures, making it the model of choice for pharmaceutical research, drug discovery pipelines, and biomedical knowledge graph applications.
Clinical Use Case → Model Selection Guide
No medical LLM — regardless of benchmark performance — should be deployed in clinical decision support without: (a) validation on your patient population and clinical workflows, (b) assessment of FDA SaMD classification, (c) clinician oversight workflows, and (d) formal clinical governance sign-off. Benchmark performance on USMLE is necessary but not sufficient evidence for clinical safety. All clinical AI deployments require a clinical governance framework and ongoing performance monitoring.
Our healthcare app development and machine learning teams have deployed HIPAA-compliant medical LLM systems for health systems, digital health companies, and payers. Book a free advisory session to scope your clinical AI programme.